Clinical Trials Browser

Phase 1 × OTHER × crenolanib × Clear all

NCT02270788 2017-10-03

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01393912 2017-04-26

PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma

Phase 1 Completed

Diffuse Intrinsic Pontine Glioma, Glioma